1. Cellphire Awarded $29.25 Million U.S. Army Cryopreserved Platelet Development Contract

    January 15, 2020 – Cellphire, the global leader in long-term stabilization and storage of platelets, announced today that the U.S. Army Medical Research Acquisition Activity (USAMRAA) has awarded the company a 6.5-year contract valued at $29.25 million (including all options) to develop a U.S. Food and Drug Administration (FDA) licensed dimethyl sulfoxide (DMSO) Cryopreserved Platelets […]